17-82921536-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_005993.5(TBCD):​c.2137C>T​(p.His713Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,614,046 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H713D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000027 ( 1 hom. )

Consequence

TBCD
NM_005993.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 2.46

Publications

2 publications found
Variant links:
Genes affected
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
TBCD Gene-Disease associations (from GenCC):
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.063402176).
BP6
Variant 17-82921536-C-T is Benign according to our data. Variant chr17-82921536-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2058015.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000256 (39/152336) while in subpopulation AFR AF = 0.000914 (38/41582). AF 95% confidence interval is 0.000684. There are 0 homozygotes in GnomAd4. There are 19 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005993.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
NM_005993.5
MANE Select
c.2137C>Tp.His713Tyr
missense
Exon 25 of 39NP_005984.3
TBCD
NM_001411101.1
c.2086C>Tp.His696Tyr
missense
Exon 24 of 38NP_001398030.1
TBCD
NM_001411102.1
c.2056C>Tp.His686Tyr
missense
Exon 24 of 38NP_001398031.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
ENST00000355528.9
TSL:1 MANE Select
c.2137C>Tp.His713Tyr
missense
Exon 25 of 39ENSP00000347719.4
TBCD
ENST00000571796.5
TSL:1
n.795C>T
non_coding_transcript_exon
Exon 10 of 17
TBCD
ENST00000576677.6
TSL:1
n.1348C>T
non_coding_transcript_exon
Exon 4 of 16

Frequencies

GnomAD3 genomes
AF:
0.000237
AC:
36
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000682
AC:
17
AN:
249278
AF XY:
0.0000370
show subpopulations
Gnomad AFR exome
AF:
0.000775
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000267
AC:
39
AN:
1461710
Hom.:
1
Cov.:
31
AF XY:
0.0000275
AC XY:
20
AN XY:
727138
show subpopulations
African (AFR)
AF:
0.000956
AC:
32
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111868
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152336
Hom.:
0
Cov.:
33
AF XY:
0.000255
AC XY:
19
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41582
American (AMR)
AF:
0.0000654
AC:
1
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000251
Hom.:
0
Bravo
AF:
0.000287
ESP6500AA
AF:
0.00140
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000908
AC:
11
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Oct 12, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2137C>T (p.H713Y) alteration is located in exon 25 (coding exon 25) of the TBCD gene. This alteration results from a C to T substitution at nucleotide position 2137, causing the histidine (H) at amino acid position 713 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

not provided Benign:1
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
9.9
DANN
Benign
0.64
DEOGEN2
Benign
0.037
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.029
N
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.063
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
2.5
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.18
Sift
Benign
0.075
T
Sift4G
Benign
1.0
T
Polyphen
0.33
B
Vest4
0.18
MVP
0.41
MPC
0.35
ClinPred
0.013
T
GERP RS
2.7
Varity_R
0.028
gMVP
0.24
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200903034; hg19: chr17-80879412; API